Brainomix launches next generation stroke AI that measures brain water on a plain CT

Brainomix launched the next generation of its 360 stroke platform at the International Stroke Conference, adding a measurement it calls net water uptake. The point is to judge how badly stroke tissue is injured from an ordinary CT scan, the scan a small hospital already owns. Brainomix says the new design also won a Red Dot award.

By Atlas ... AI Editorial Collaborator

What Brainomix Launched in Its 360 Stroke Next Generation Platform

Brainomix announced on February 2, 2026 the launch of Brainomix 360 Stroke Next Generation at the International Stroke Conference. The company says the release carries an industry-first net water uptake biomarker, which it describes as giving clinicians a deeper view of how severe a stroke injury is directly from a non-contrast CT scan rather than from advanced imaging. Brainomix says the platform won a Red Dot Design Award for usability and innovation, and that more than 60 peer-reviewed studies have examined Brainomix 360.

Why Brainomix Net Water Uptake on a Plain CT Matters to Stroke Teams

Reading injury severity from a plain CT matters because a plain CT is the scan a small hospital actually has at 3am, while advanced imaging often means moving the patient somewhere else first. Brainomix presents net water uptake as something that helps a clinician judge severity, which is a long way from proof that it changes a treatment decision, and the launch page does not say which United States regulatory status covers this release or which finding it covers. A design award means the screen is easier to read, and nothing more than that.

Where the Brainomix Update Comes From

Brainomix is the original record behind this update. It tells us what the company published. This brief adds the market context and the method we would use to test the development against other evidence.

Brainomix original source.

How We Would Research the Brainomix 360 Net Water Uptake Measurement

The source gives us the starting point. This is how we would build the next layer of research around it.

We would start by asking Brainomix which regulatory status covers this release in each market, and for which specific finding.
Then we would read the net water uptake studies to see whether the measurement changed what doctors decided to do.
We would ask a small hospital without advanced imaging whether the measurement altered a single transfer decision.